MND-SMART team releases update about trial drug amantadine
18 December 2024
The MND Association welcomes today’s announcement from the MND-SMART team confirming the drug amantadine will continue to be evaluated as part of the MND-SMART platform trial.
We will share resources to the email address you provide. The email will include your name in the subject line and the following message: 'I have found these information resources that you may find helpful too.'
Email sent successfully
We have shared these resources with the email address you entered.